Director, BioPharma R&D Strategy Analyst

As a Director,
Bio Pharma R&D Strategy Analyst you will be responsible for connecting R&D strategy with commercial forecasting to improve the quality and impact of cross-functional decision-making.
Working across R&D and Commercial in a multidisciplinary team environment, the Director will lead the development of long-term therapy area projections and strategic analyses that identify areas of high unmet need and inform portfolio prioritization.
This role requires the ability to integrate scientific, clinical, and commercial perspectives to support decision-making across disease area evolution, future treatment landscapes, and emerging technologies.
The Director will partner closely with stakeholders across science, clinical development, business development, competitive intelligence, and early commercial to generate pragmatic, scenario-based insights that shape strategy.
The role will also work closely with Commercial forecasting leads to ensure long-term views of disease area evolution remain current as assets progress.

AstraZeneca is a global, science-led biopharmaceutical company and our innovative medicines are used by millions of patients worldwide. This is the place to make an impact. Here we ensure everyone can reach their full potential, perform at their best and make a valued contribution to the enterprise. Within Biopharmaceuticals R&D, we are empowered to be bold, take calculated risks and use our intelligence and courage to always follow the science.

Our team is being built to sit at the center of Biopharmaceuticals R&D – driving our R&D strategy and addressing the unmet needs and future focus of AstraZeneca’s Biopharmaceuticals pipeline. We operate both internally and externally, leading collaboration and acquisition opportunities as well as partnering closely with external alliances.

• Create high level long-term projections for R&I or CVRM disease areas using patient-based and market-based models to inform early portfolio prioritisation, target profile choices, and modality selection for pre-commercial assets and disease areas
• Support R&D decision making when selecting or prioritizing new targets, modalities, indications, therapy areas, asset opportunities, external innovation, and partnering options
• Integrate primary research, epidemiology, competitive intelligence, translational and clinical insights, external landscape signals, scientific milestones, access dynamics, and real-world data into projection models
• Proactively identify and quantify key risks and opportunities through scenario and sensitivity analyses, competitor readouts, and deal-related value assumptions
• Partner closely with R&D strategy, project teams, business development and alliances, finance, and competitive intelligence to ensure alignment on assumptions and implications, and connect with Commercial forecasting teams.

• Provide leadership over forecasting-adjacent analytics, ensuring advanced analytics and insights are embedded into R&D strategy, portfolio reviews, and evidence planning
• Manage and prioritise external vendors supporting projections, analytics, competitive intelligence, and landscape assessment deliverables
• Partner with data analytics resources, Global IA&F, and R&D, BD&L and CI capability teams to ensure alignment with new tools, data sources, and modelling approaches
• Champion and identify new ways to embed AI and advanced automation into the practice of data analytics and projections to drive efficiency,…